Skip to main content
. 2024 Feb 29;36(1):90–102. doi: 10.21147/j.issn.1000-9604.2024.01.09

Figure 2.

Figure 2

Comparisons of significant gene alteration frequency of GEPNEC and LNEC patients. (A) Oncoprints showing the top most frequent and significant gene alterations between GEPNEC and LNEC; (B) Bar plots of pathway alteration proportions of GEPNEC and LNEC. GEPNEC, gastroenteropancreatic neuroendocrine carcinoma; LNEC, lung NEC. P values were determined using Fisher’s exact test. *, P<0.05; **, P<0.01.